Clinical Trial Update: The Efficacy and Safety of Pola-ZR2 Versus ZR2 in the Treatment of Old Patients With de Novo Diffuse Large B-cell Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Pola-ZR2 to ZR2 in older patients with de Novo Diffuse Large B-Cell Lymphoma; currently recruiting to evaluate efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Pola-ZR2
• ZR2

Snippet

Sponsor: Ruijin Hospital | Conditions: Diffuse Large B-Cell Lymphoma | Phase 3 | Status: RECRUITING